Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study
Public ClinicalTrials.gov record NCT02949297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective clinical evaluation of the effectiveness of the Ovation Alto Abdominal Stent Graft System when used in the treatment of subjects with abdominal aortic aneurysm (AAA).
Study identification
- NCT ID
- NCT02949297
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2017
- Primary completion
- Mar 5, 2019
- Completion
- Mar 5, 2019
- Last update posted
- Dec 21, 2021
2017 – 2019
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Abrazo Arizona Heart Hospital | Phoenix | Arizona | 85016 | — |
| VA San Diego | San Diego | California | 92161 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Carle Foundation Hospital | Urbana | Illinois | 61801 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| New Mexico Heart Institute | Albuquerque | New Mexico | 87102 | — |
| University at Buffalo Clinical Translational Research Center/Kaleida Health/GVI/Buffalo General Medical Center | Buffalo | New York | 14203 | — |
| Mission Hospital | Asheville | North Carolina | 28801 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| North Central Heart | Sioux Falls | South Dakota | 57108 | — |
| Wellmont CVA Heart Institute | Kingsport | Tennessee | 37660 | — |
| Baylor St. Luke's Medical Center | Houston | Texas | 77030 | — |
| Swedish Heart and Vascular Research | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02949297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2021 · Synced Sep 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02949297 live on ClinicalTrials.gov.